Evolving New Treatment for Myelodysplastic Syndromes

スポンサーリンク

概要

• 論文の詳細を見る
• 2007-11-15

著者

• YOSHIDA Yataro

  Takeda General Hospital

関連論文

• Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality
• A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome : Presence of CD55^-CD59^- Blood Cells Predicts Platelet Response
• Peer Review System : Any Other Choice?
• Evolving New Treatment for Myelodysplastic Syndromes
• The aplasia-myelodysplasia enigma:a re-emerging question
• A Eulogy for Dr. Gyouichi Wakisaka
• Seventh International Symposium on Myelodysplastic Syndromes

スポンサーリンク